Provided by Tiger Trade Technology Pte. Ltd.

Tempus AI

58.74
-2.5400-4.14%
Post-market: 58.73-0.0100-0.02%17:32 EDT
Volume:5.47M
Turnover:324.34M
Market Cap:10.66B
PE:-40.97
High:61.11
Open:59.87
Low:58.02
Close:61.28
52wk High:104.32
52wk Low:40.77
Shares:181.56M
Float Shares:115.00M
Volume Ratio:1.01
T/O Rate:4.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4337
EPS(LYR):-1.4100
ROE:-67.44%
ROA:-8.55%
PB:23.97
PE(LYR):-41.66

Loading ...

BofA's Hartnett: The 2026 Midterms Will Decide It — AI Bull Market Either Melts Up Into 2027, Or Drops More Than 10%

AI Industry Frontlines
·
Aug 14

Is The Token No Longer The Yardstick? OpenAI And Anthropic Are Rewriting The Rules For Premium AI

AI Industry Frontlines
·
Aug 14

AI Software Shares Jump. AppLovin, Cloudflare up Around 4%; Palantir up over 3%; Trade Desk, Datadog, Shopify, Duolingo up over 2%

Tiger Newspress
·
Aug 13

Tempus AI CEO Data Ryan Fukushima Disposes of 20.000 Shares Worth $1 Juta

Reuters
·
Aug 12

AI Software Shares Rise. Tempus AI up 7%; Datadag up Nearly 5%; Spotify, Duolingo, Braze up over 4%; Roblox, Snowflake, Figma up over 2%

Tiger Newspress
·
Aug 10

Movement Alert|Tempus AI Intraday Rise 5.1%, Q2 Earnings Beat and Raised Full-Year Guidance Continue to Drive Momentum

Market Focus
·
Aug 10

Tempus AI (TEM) After CellCarta Deal And PRISM2 Validation Faces A Fresh Valuation Test

Simply Wall St.
·
Aug 10

Why Tempus AI (TEM) Is Up 18.6% After Joining CellCarta’s CDx Commercialization Lab Network

Simply Wall St.
·
Aug 08

Movement Alert|Tempus AI Rises 6.07% in Regular Trading, Boosted by AI Software Sector Rally and Strong Q2 Earnings

Market Focus
·
Aug 07

Cellcarta: Adds Tempus to Cdx Commercialization Lab Network as Second Commercial Lab Partner

THOMSON REUTERS
·
Aug 06

Tempus AI CEO, Data Ryan Fukushima Reports Disposal of 23,818 Common Shares Worth $1.1 Million

Reuters
·
Aug 06

Tempus AI announces study results of PRISM2

TIPRANKS
·
Aug 04

Tempus AI Inc : Btig Cuts Target Price to $70 from $80

THOMSON REUTERS
·
Aug 04

JPMorgan: The AI Trade Won't Lead the Market in the Second Half

Analyst Calls
·
Aug 04

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
Aug 04

Tempus AI price target lowered to $56 from $64 at H.C. Wainwright

TIPRANKS
·
Aug 04

Movement Alert|Tempus AI Rises 5.08% in Regular Trading, Q2 Earnings Beat and Raised Full-Year Guidance Fuel Continued Rally

Market Focus
·
Aug 03

Tempus AI is Maintained at Hold by Stifel

Dow Jones
·
Aug 03

Tempus AI–Personalis Deal: Integration Risks, Rising Costs, and Regulatory Scrutiny Could Undermine Synergy Gains

TIPRANKS
·
Aug 01

Tempus AI Price Target Maintained with a $75.00/Share by Needham

Dow Jones
·
Jul 31